Neonatal/Infant Resuscitation 2
Juin Yee Kong, MD (she/her/hers)
Kk women’s and children’s hospital
This is a pilot randomized controlled trial. Preterm infants < 32 weeks gestation who require mPPV after birth were randomized into control group versus monitor group. In the monitor group, ETCO2 detector is attached to facemask to guide mPPV by observation of colour change when breaths were effective. In the control group, routine assessment of effective breaths as per NRP guidelines was practiced. Physiologic data, respiratory data and video recordings were collected. Primary outcome is defined as combined duration of bradycardia (HR< 100bpm) and desaturation (SpO2 levels below recommended target). Secondary outcomes were need for DR interventions. Statistical analysis was performed using SPSS.
A convenient sample of 50 patients were enrolled in the study from 6 Jun 2019 to 15 Feb 2021. Data for 47 subjects were available for analysis. Birthweight and gestational age were similar in both groups. Median BDI for both groups were 196s [28,235] in monitor group vs 188s [74,349]in control group, p=0.44. Incidence of intubation, chest compression and epinephrine administration in the DR were not statistically different. There were no DR deaths in the study cohort.